| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/25/1999 | DE19824306A1 Fibrin glue useful in tissue engineering, biotechnology and surgery |
| 11/25/1999 | DE19822954A1 Ki-67 gene antisense oligonucleotide |
| 11/25/1999 | DE19822820A1 Wound healing composition comprising lipopeptide or lipoprotein that stimulates leukocyte infiltration |
| 11/25/1999 | DE19822406A1 Composition for treating cancer and other diseases caused by pathogenic proteins |
| 11/25/1999 | DE19821971A1 Composition for treating psoriasis or neurodermatitis |
| 11/25/1999 | DE19806803A1 Transporter für Saccharid-gekoppelte Zytostatika in Tumorzellen Transportation for saccharide-linked cytotoxic agents in tumor cells |
| 11/25/1999 | CA2690399A1 Il-6 antagonist peptides |
| 11/25/1999 | CA2332774A1 Method for the treatment of gastroesophageal reflux disease |
| 11/25/1999 | CA2332531A1 Protease inhibitors |
| 11/25/1999 | CA2332507A1 Angiostatin receptor |
| 11/25/1999 | CA2332492A1 Protease inhibitors |
| 11/25/1999 | CA2332338A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 11/25/1999 | CA2332331A1 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases |
| 11/25/1999 | CA2332272A1 Novel analogs of 16-hydroxyeicosatetraenoic acid |
| 11/25/1999 | CA2332270A1 Cyclosporin preparations |
| 11/25/1999 | CA2331875A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 11/25/1999 | CA2331823A1 Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having g chronic hepatitis c infection |
| 11/25/1999 | CA2330471A1 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots |
| 11/25/1999 | CA2329901A1 Assays, methods and means for modulating e2f activity |
| 11/25/1999 | CA2329868A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products |
| 11/25/1999 | CA2329130A1 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 11/25/1999 | CA2328605A1 Protein z-dependent protease inhibitor |
| 11/25/1999 | CA2328603A1 Novel compositions comprising interleukin-18 and a chemotherapeutic agent |
| 11/25/1999 | CA2328596A1 Cytosine deaminase gene |
| 11/25/1999 | CA2328529A1 Immunoregulator from a human chorionic gonadotropin preparation |
| 11/25/1999 | CA2328527A1 Secreted proteins |
| 11/25/1999 | CA2328510A1 Human nucleic acid methylases |
| 11/25/1999 | CA2328509A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions |
| 11/25/1999 | CA2328501A1 Prevention and treatment of hypergastrinemia |
| 11/25/1999 | CA2328496A1 Il-17 homologous polypeptides and therapeutic uses thereof |
| 11/25/1999 | CA2328489A1 Secreted proteins and polynucleotides encoding them |
| 11/25/1999 | CA2328144A1 Multivalent t cell receptor complexes |
| 11/25/1999 | CA2327314A1 Soluble t cell receptor |
| 11/25/1999 | CA2327100A1 Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives |
| 11/25/1999 | CA2325600A1 Methods for amyloid removal using anti-amyloid antibodies |
| 11/24/1999 | EP0958834A1 Peptide immunotherapeutic agent |
| 11/24/1999 | EP0958833A1 Methods and means for preventing or treating inflammation |
| 11/24/1999 | EP0958832A2 Albumin containing peritoneal dialysis fluid |
| 11/24/1999 | EP0958831A1 Ophthalmic compositions of neurotrophic factors, remedies for optic nerve function disorders and method for treating optic nerve function disorders |
| 11/24/1999 | EP0958830A1 Immunoregulator from pregnant mammals |
| 11/24/1999 | EP0958829A1 Use of a peptide compound in the treatment of systemic lupus erythematosus |
| 11/24/1999 | EP0958816A2 Medicament for the treatment of diabetes mellitus as well as its subsequent disorders |
| 11/24/1999 | EP0958780A1 Sensor system with permanently implanted access |
| 11/24/1999 | EP0958382A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 11/24/1999 | EP0958377A1 Process for identification of genes encoding proteins having cell proliferation-promoting activity |
| 11/24/1999 | EP0958374A1 T1 receptor-like ligand i |
| 11/24/1999 | EP0958371A2 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 11/24/1999 | EP0958369A1 Cationic polymer and lipoprotein-containing system for gene delivery |
| 11/24/1999 | EP0958366A1 Human chemokine beta-13 |
| 11/24/1999 | EP0958365A1 Granulocyte chemotactic protein 2 variant |
| 11/24/1999 | EP0958364A1 Immunotherapy and improved vaccines |
| 11/24/1999 | EP0958363A1 Human regulator of g-protein signaling - (hrgs) |
| 11/24/1999 | EP0958362A1 Isolation and use of motoneuronotrophic factors |
| 11/24/1999 | EP0958361A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 11/24/1999 | EP0958360A2 Secreted proteins and polynucleotides encoding them |
| 11/24/1999 | EP0958358A1 Method for preparing a plasmid dna |
| 11/24/1999 | EP0958357A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 11/24/1999 | EP0958305A2 Inhibitions of the interaction between p53 and mdm2 |
| 11/24/1999 | EP0958304A1 Nucleotide sequence encoding the cd33-like protein |
| 11/24/1999 | EP0958283A1 New compounds with hemoregulating effect |
| 11/24/1999 | EP0957943A1 Matrix-free osteogenic devices, implants and methods of use thereof |
| 11/24/1999 | EP0957941A1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE |
| 11/24/1999 | EP0957937A1 VACCINES, ANTIBODIES, PROTEINS, GLYCOPROTEINS, DNAS AND RNAS FOR PROPHYLAXIS AND TREATMENT OF $i(CRYPTOSPORIDIUM PARVUM) INFECTIONS |
| 11/24/1999 | EP0957935A1 Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and methods of preparation thereof |
| 11/24/1999 | EP0957932A2 A method and composition for enabling passage through the blood-brain barrier |
| 11/24/1999 | EP0957931A1 Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant |
| 11/24/1999 | EP0957930A2 Substance p treatment for immunostimulation |
| 11/24/1999 | EP0957929A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 11/24/1999 | EP0957926A1 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein |
| 11/24/1999 | EP0957924A1 Certain phosphinyl derivatives useful as naaladase inhibitors |
| 11/24/1999 | EP0957902A1 System for genetically treating cardiac conduction disturbances |
| 11/24/1999 | EP0957901A1 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 11/24/1999 | EP0845045A4 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 11/24/1999 | EP0833653A4 Serum immunoregulatory polypeptides and uses therefor |
| 11/24/1999 | EP0808165A4 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
| 11/24/1999 | EP0797663A4 Sox-9 gene and protein and use in the regeneration of bone or cartilage |
| 11/24/1999 | EP0753060A4 Conserved t-cell receptor sequences |
| 11/24/1999 | EP0730470A4 Improved interferon polymer conjugates |
| 11/24/1999 | EP0666756B1 Method of producing analgesia using neurotrophins |
| 11/24/1999 | EP0662836B1 Germicidal detergent-iodine compositions having reduced detergent content |
| 11/24/1999 | EP0650366B1 Compositions and methods for treating wounds |
| 11/24/1999 | CN1236393A Chitinase materials and methods |
| 11/24/1999 | CN1236392A Phsopholipase D and DNA sequences |
| 11/24/1999 | CN1236390A Angiogenic factor and use thereof of treating cardiovascular disease |
| 11/24/1999 | CN1236370A Chemically modified polypeptides |
| 11/24/1999 | CN1236320A Therapeutic uses of BPI protein products for human meningococcemia |
| 11/24/1999 | CN1235980A Human calcitonin analogue |
| 11/24/1999 | CN1235846A Medicine preparation administrated through nasal mucosa |
| 11/24/1999 | CN1235824A Process for producing enteric coated pancreatin granules |
| 11/24/1999 | CN1046737C Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for determination thereof |
| 11/24/1999 | CN1046635C Composition and mether using nitrooxides to avoid oxygen toxicity |
| 11/23/1999 | US5990388 Transgenic plant expressing a cloned dna encoding a vaccinia virus e3l protein at a level to complex and sequester double-stranded rna-like structure of virus/viroid; biological pest control; viricides |
| 11/23/1999 | US5990299 Control of CD44 gene expression for therapeutic use |
| 11/23/1999 | US5990297 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
| 11/23/1999 | US5990296 Improving binding affinity of single chain lewis-y antibodies by replacing amino acid at position 95 with serine; immunotoxins for anticarcinogenic/antitumor agents |
| 11/23/1999 | US5990294 Antitumor/anticarcinogenic/antiproliferative agents; treatment and diagnosis of degenerative or growth deficiency disorders |
| 11/23/1999 | US5990287 Immunoglobulin which binds to surface antigen of stomach cancer cell mnk45 and colon cancer cell c-1; for diagnosis of cancer; for anticarcinogenic agents and immunotoxins |
| 11/23/1999 | US5990286 Antibodies with reduced net positive charge |
| 11/23/1999 | US5990285 Catalytic antibodies against cocaine |
| 11/23/1999 | US5990282 Receptor protein for human B cell stimulatory factor-2 |